Concepedia

Author

Lameh Fananapazir

National Heart Lung and Blood Institute

Also Known As

L Fananapazir, L. FANANAPAZIR, L. Fananapazir, LAMEH FANANAPAZIR, Lameh Fananapazir

124

Publications

8.7K

Citations

46

H-Index

95

Concepts

All Affiliations

National Heart Lung and Blood InstituteNational Institutes of HealthWythenshawe HospitalDuke Medical Center
LF

About

Lameh Fananapazir is an author at National Heart Lung and Blood Institute specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

34

43

4.5K

2

Health Sciences

8

8

853

3

Arts

1

1

175

4

Engineering

1

1

131

5

Natural Sciences

1

1

82

Lameh Fananapazir

×

67

Publications

8.4K

Citations

45

H-Index

YearCitations

Identification of a Gene Responsible for Familial Wolff–Parkinson–White Syndrome

Michael H. Gollob, Martin S. Green, Anthony Tang,

New England Journal of Medicine

2001

667

Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle

Karl Poetter, He Jiang, Shahin Hassanzadeh,

Nature Genetics

1996

583

Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.

Lameh Fananapazir, Nava Epstein, Rodolfo Curiel,

Circulation

1994

383

Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.

Lameh Fananapazir, R O Cannon, Dominique Tripodi,

Circulation

1992

296

Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy

Vasken Dilsizian, Robert O. Bonow, Stephen E. Epstein,

Journal of the American College of Cardiology

1993

276

Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings.

Lameh Fananapazir, Anthony Chang, Stephen E. Epstein,

Circulation

1992

261

Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.

Giovanni Cuda, Lameh Fananapazir, Wahwah Zhu,

Journal of Clinical Investigation

1993

242

Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.

Nava Epstein, Gabriel Cohn, F Cyran,

Circulation

1992

230

Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure

Juey‐Jen Hwang, Paul D. Allen, George C. Tseng,

Physiological Genomics

2002

227

Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries

Richard O. Cannon, Arshed A. Quyyumi, William H. Schenke,

Journal of the American College of Cardiology

1990

226

Page 1